A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...
A real-world analysis found that mRNA SARS-CoV-2 vaccination was associated with lower 3-year mortality after CAR T-cell therapy in patients with hematologic malignancies.
A real-world analysis found that mRNA SARS-CoV-2 vaccination was associated with lower 3-year mortality after CAR T-cell therapy in patients with hematologic malignancies.
A real-world analysis found that mRNA SARS-CoV-2 vaccination was associated with lower 3-year mortality after CAR T-cell therapy in patients with hematologic malignancies.
Updated 5-year data from KEYNOTE-942 showed that intismeran autogene plus pembrolizumab maintained durable recurrence-free and distant metastasis-free survival benefits in patients with high-risk resected...
Updated 5-year data from KEYNOTE-942 showed that intismeran autogene plus pembrolizumab maintained durable recurrence-free and distant metastasis-free survival benefits in patients with high-risk resected...
Updated 5-year data from KEYNOTE-942 showed that intismeran autogene plus pembrolizumab maintained durable recurrence-free and distant metastasis-free survival benefits in patients with high-risk resected...
Featured faculty at The Revolution & Paradigm Shift in Treatment of Migraine, scheduled for July 16-17, 2026, will highlight evolving approaches to migraine diagnosis, prevention, disease burden, and...
Featured faculty at The Revolution & Paradigm Shift in Treatment of Migraine, scheduled for July 16-17, 2026, will highlight evolving approaches to migraine diagnosis, prevention, disease burden, and...
Featured faculty at The Revolution & Paradigm Shift in Treatment of Migraine, scheduled for July 16-17, 2026, will highlight evolving approaches to migraine diagnosis, prevention, disease burden, and...
